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Introduction
Necrotising enterocolitis (NEC) is one of the most
unpredictable and devastating diseases in premature
infants. It is a big and costly problem especially for
infants who are born with very low birth weight
(VLBW).
Objectives
The aim of this study was descriptive epidemiology of
NEC in a representative group of very low birth weight
Polish newborns.
Methods
The study covered 910 children with VLBW hospitalized
in six neonatal intensive care units in Poland. Case
patients were defined according to NeoKISS as VLBW
neonates who had clinical symptoms of necrotising
enterocolitis (NEC).
Data on potential risk factors which occurred during
pregnancy and hospitalization in NICUs, results of
microbiological tests and antibiotic treatment were gath-
ered in the year 2009.
Two kinds of indicators were used for the description
of antibiotic usage: the duration of treatment (days of
treatment, DOTs) expressed in days and the defined
daily dose (DDD), according to the ATC/DDD system.
Results
NEC incidence was 8.7% (12.7% of all cases of infec-
tions) and mortality rate was 19%. The risk of NEC
development did not differ between NICUs. Chorioam-
nionitis, late gestational age and low birth weights was
identified as a risk factor of NEC.
Catheterization, mechanical ventillation, antibiotic use
and other selected procedures were used for a signifi-
cantly longer period of time in newborns with NEC
than in remaining neonates.
2.9 DDDs of antibiotics were used for treatment of
NEC and total treatment duration was 1,437 days; the
average use of drugs in this group amounted to 0.47
DDD or 23.18 days per case. Level of antbiotic usage
was analyzed with correlation to microbiological tests
performed and it was non-significantly greater in the
group of children with NEC in whom the tests were
done.
Conclusion
A high risk of developing NEC was closely associated
with such factors as: a very low infant birth weight,
inflammation of the amnion during labour and the use
of invasive procedures. No relationship between the
consumption of antibiotics or sepsis accompanying NEC
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